Dialogue between neuroinflammation and neurodegenerative diseases in COVID-19

B Chowdhury, A Sharma, S Satarker… - Journal of …, 2021 - dl.begellhouse.com
It has now been almost a year since the emergence of the deadly SARS-CoV-2 with millions
of people losing their lives due to resultant COVID-19. Apart from the well-known …

COVID-19 and long COVID: disruption of the neurovascular unit, blood-brain barrier, and tight junctions

D Kempuraj, KK Aenlle, J Cohen… - The …, 2024 - journals.sagepub.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), could affect brain structure and function. SARS-CoV …

Neurological and neuropsychological changes associated with SARS-CoV-2 infection: new observations, new mechanisms

MA Haidar, H Jourdi, Z Haj Hassan… - The …, 2022 - journals.sagepub.com
SARS-CoV-2 infects cells through angiotensin-converting enzyme 2 (ACE2), a ubiquitous
receptor that interacts with the virus' surface S glycoprotein. Recent reports show that the …

Neuroinflammation and Its Impact on the Pathogenesis of COVID-19

MM Almutairi, F Sivandzade, TH Albekairi… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …

Neuronal and cerebrovascular complications in coronavirus disease 2019

MS Andrabi, SA Andrabi - Frontiers in Pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a pandemic disease resulting from severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, primarily in the respiratory …

An overview of the neurological aspects in COVID-19 infection

D Singh, E Singh - Journal of Chemical Neuroanatomy, 2022 - Elsevier
The Crown-shaped, severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2)
triggered the globally fatal illness of Coronavirus disease-2019 (COVID-19). This infection is …

Emerging neurotropic features of SARS-CoV-2

WR Zhan, J Huang, PM Zeng, WY Tian… - Journal of Molecular …, 2021 - academic.oup.com
The prevailing coronavirus disease-19 (COVID-19) caused by a novel severe acute
respiratory syndrome coronavirus (SARS-CoV-2) has presented some neurological …

[HTML][HTML] Complications of COVID-19 on the Central Nervous System: Mechanisms and Potential Treatment for Easing Long COVID

ZYD Wei, K Liang, AK Shetty - Aging and Disease, 2023 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) invades human cells by
binding to the angiotensin-converting-enzyme-2 (ACE-2) using a spike protein and leads to …

A peek into Pandora's box: COVID-19 and neurodegeneration

A Chandra, A Johri - Brain Sciences, 2022 - mdpi.com
Ever since it was first reported in Wuhan, China, the coronavirus-induced disease of 2019
(COVID-19) has become an enigma of sorts with ever expanding reports of direct and …

Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics

A Leng, M Shah, SA Ahmad, L Premraj, K Wildi… - Cells, 2023 - mdpi.com
The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …